Elite, a specialty pharmaceutical company, is introducing its generic Adderall XR via its marketing partner Lannett. Adderall XR is a once-daily central nervous system stimulant and is indicated for ...
Elite has received the Food and Drug Administration’s green light for a generic version of Shire’s Adderall XR. The product is an extended-release mixed salt of a single-entity amphetamine product ...
Becca Stanek is an experienced writer and editor who is passionate about exploring the ways we can feel better mentally and physically to get the most out of our lives. She has worked for publications ...
Las Vegas, NV – November 8, 2005 – ADDERALL XR® (mixed salts of a single-entity amphetamine product) significantly improved driving performance, cognitive ...
Shire has reached a long-awaited settlement over patent litigation with Barr Pharmaceuticals over Barr’s attempt to market generic versions of Shire’s attention deficit hyperactivity disorder (ADHD) ...
San Diego, CA, November 19, 2004 – The Washington Neuropsychological Institute today announced that preliminary data suggested that ADDERALL XR ® significantly improved simulated driving performance ...
ENGLEWOOD, CO / ACCESSWIRE / January 10, 2023 / Millions of ADHD patients in the United States rely on FDA approved treatments to control their ADHD symptoms and many of them are currently struggling ...
NORTHVALE, NJ / ACCESSWIRE / December 12, 2019 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing its own generic products, partnered ...
Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...
Josh Disbrow is chairman and CEO of Aytu BioPharma, which makes a competing drug to treat ADHD called Adzenys XR-ODT. A nationwide shortage of Adderall has left many patients struggling to manage ...
Adderall (amphetamine/dextroamphetamine) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to treat attention deficit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results